List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Human Somatotropin Product Introduction
1.2 Global Human Somatotropin Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Somatotropin Sales in US$ Million for the Year 2017-2028
1.2.2 Global Human Somatotropin Sales in Volume for the Year 2017-2028
1.3 United States Human Somatotropin Outlook 2017 VS 2022 VS 2028
1.3.1 United States Human Somatotropin Sales in US$ Million for the Year 2017-2028
1.3.2 United States Human Somatotropin Sales in Volume for the Year 2017-2028
1.4 Human Somatotropin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Human Somatotropin in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Human Somatotropin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Human Somatotropin Market Dynamics
1.5.1 Human Somatotropin Industry Trends
1.5.2 Human Somatotropin Market Drivers
1.5.3 Human Somatotropin Market Challenges
1.5.4 Human Somatotropin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Human Somatotropin Market Segment by Type
2.1.1 Powder
2.1.2 Solvent
2.2 Global Human Somatotropin Market Size by Type
2.2.1 Global Human Somatotropin Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Human Somatotropin Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Human Somatotropin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Human Somatotropin Market Size by Type
2.3.1 United States Human Somatotropin Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Human Somatotropin Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Human Somatotropin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Human Somatotropin Market Segment by Application
3.1.1 Growth Hormone Deficiency (GHD)
3.1.2 Turner Syndrome
3.1.3 Chronic Renal Insufficiency
3.1.4 Prader Willi Syndrome
3.1.5 Small for Gestational Age
3.1.6 SHOX Deficiency
3.1.7 Others
3.2 Global Human Somatotropin Market Size by Application
3.2.1 Global Human Somatotropin Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Human Somatotropin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Human Somatotropin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Human Somatotropin Market Size by Application
3.3.1 United States Human Somatotropin Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Human Somatotropin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Human Somatotropin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Somatotropin Competitor Landscape by Company
4.1 Global Human Somatotropin Market Size by Company
4.1.1 Top Global Human Somatotropin Manufacturers Ranked by Revenue (2021)
4.1.2 Global Human Somatotropin Revenue by Manufacturer (2017-2022)
4.1.3 Global Human Somatotropin Sales by Manufacturer (2017-2022)
4.1.4 Global Human Somatotropin Price by Manufacturer (2017-2022)
4.2 Global Human Somatotropin Concentration Ratio (CR)
4.2.1 Human Somatotropin Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Somatotropin in 2021
4.2.3 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Somatotropin Manufacturing Base Distribution, Product Type
4.3.1 Global Human Somatotropin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Human Somatotropin Product Type
4.3.3 Date of International Manufacturers Enter into Human Somatotropin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Human Somatotropin Market Size by Company
4.5.1 Top Human Somatotropin Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Somatotropin Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Human Somatotropin Sales by Players (2020, 2021 & 2022)
5 Global Human Somatotropin Market Size by Region
5.1 Global Human Somatotropin Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Somatotropin Market Size in Volume by Region (2017-2028)
5.2.1 Global Human Somatotropin Sales in Volume by Region: 2017-2022
5.2.2 Global Human Somatotropin Sales in Volume Forecast by Region (2023-2028)
5.3 Global Human Somatotropin Market Size in Value by Region (2017-2028)
5.3.1 Global Human Somatotropin Sales in Value by Region: 2017-2022
5.3.2 Global Human Somatotropin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Somatotropin Market Size YoY Growth 2017-2028
6.1.2 North America Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Somatotropin Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Somatotropin Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Indonesia
6.2.9 Thailand
6.2.10 Malaysia
6.2.11 Philippines
6.2.12 Vietnam
6.3 Europe
6.3.1 Europe Human Somatotropin Market Size YoY Growth 2017-2028
6.3.2 Europe Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Somatotropin Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Somatotropin Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporation Information
7.1.2 Novo Nordisk Description and Business Overview
7.1.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novo Nordisk Human Somatotropin Products Offered
7.1.5 Novo Nordisk Recent Development
7.2 Pfizer
7.2.1 Pfizer Corporation Information
7.2.2 Pfizer Description and Business Overview
7.2.3 Pfizer Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pfizer Human Somatotropin Products Offered
7.2.5 Pfizer Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Eli Lilly Human Somatotropin Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Merck Serono
7.4.1 Merck Serono Corporation Information
7.4.2 Merck Serono Description and Business Overview
7.4.3 Merck Serono Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Merck Serono Human Somatotropin Products Offered
7.4.5 Merck Serono Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Corporation Information
7.5.2 F. Hoffmann-La Roche Description and Business Overview
7.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Ferring Pharmaceuticals
7.6.1 Ferring Pharmaceuticals Corporation Information
7.6.2 Ferring Pharmaceuticals Description and Business Overview
7.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
7.6.5 Ferring Pharmaceuticals Recent Development
7.7 GeneScience Pharmaceuticals
7.7.1 GeneScience Pharmaceuticals Corporation Information
7.7.2 GeneScience Pharmaceuticals Description and Business Overview
7.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
7.7.5 GeneScience Pharmaceuticals Recent Development
7.8 Ipsen
7.8.1 Ipsen Corporation Information
7.8.2 Ipsen Description and Business Overview
7.8.3 Ipsen Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Ipsen Human Somatotropin Products Offered
7.8.5 Ipsen Recent Development
7.9 LG Life Sciences
7.9.1 LG Life Sciences Corporation Information
7.9.2 LG Life Sciences Description and Business Overview
7.9.3 LG Life Sciences Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.9.4 LG Life Sciences Human Somatotropin Products Offered
7.9.5 LG Life Sciences Recent Development
7.10 Sandoz International
7.10.1 Sandoz International Corporation Information
7.10.2 Sandoz International Description and Business Overview
7.10.3 Sandoz International Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Sandoz International Human Somatotropin Products Offered
7.10.5 Sandoz International Recent Development
7.11 Anhui Anke Biotechnology
7.11.1 Anhui Anke Biotechnology Corporation Information
7.11.2 Anhui Anke Biotechnology Description and Business Overview
7.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Anhui Anke Biotechnology Human Somatotropin Products Offered
7.11.5 Anhui Anke Biotechnology Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Human Somatotropin Industry Chain Analysis
8.2 Human Somatotropin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Human Somatotropin Distributors
8.3 Human Somatotropin Production Mode & Process
8.4 Human Somatotropin Sales and Marketing
8.4.1 Human Somatotropin Sales Channels
8.4.2 Human Somatotropin Distributors
8.5 Human Somatotropin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
